Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03338361
Other study ID # EC/2017/1079
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 26, 2017
Est. completion date February 29, 2020

Study information

Verified date December 2021
Source University Ghent
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators evaluate the efficacy of a computerised program (T.O.P. tool) consisting of an approach avoidance training (AAT) (to retrain action tendencies for alcohol-related stimuli), a visual probe training (VPT) (to retrain attentional bias for alcohol-related stimuli) and the combination of both training procedures versus placebo training, as an add-on to treatment as usual (psycho-education and cognitive behavioral therapy). The investigators include hospitalized detoxified alcohol-dependent patients, who receive a four week training procedure, existing of a pre-assessment, 6 training sessions and a post-assessment. Outcome measures consist of behavioral measures (consumption of alcohol - self report over 1 year), questionnaires (AUDIT; craving on 9-point likert scale) and approach avoidance and visual probe measurement tasks. A six month and 1 year follow-up is included (behavioral measures and AUDIT). Further, the investigators will also assess credibility (9-point likert scale) of the training procedure before the start of the training and immediately after the assessment of the AAT and VPT training.


Recruitment information / eligibility

Status Completed
Enrollment 247
Est. completion date February 29, 2020
Est. primary completion date February 29, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - hospitalized alcohol-dependent patients, choosing for abstinence en committed to treatment - detoxification (with benzodiazepines) is terminated - Dutch speaking Exclusion Criteria: - neurological condition, such as Korsakoff syndrome - cognitive problems (cut-off <26/30 on the Montral Cognitive Assessment) - psychotic disorders - visual and motor problems at the hands - non-Dutch speaking - mental retardation - patients who are illiterate

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
active approach avoidance training and sham visual probe training
patients receive active AAT training and sham VPT training
sham approach avoidance training and active visual probe training
patients receive sham AAT training and active VPT training
active approach avoidance training and active visual probe training
patients receive active AAT training and active VPT training
sham approach avoidance training and sham visual probe training
patients receive sham AAT training and sham VPT training

Locations

Country Name City State
Belgium University Ghent Ghent

Sponsors (4)

Lead Sponsor Collaborator
University Ghent PZ Heilig Hart, PZ Sint-Camillus, University of Amsterdam

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Other change in drinking behavior score of AUDIT-c (first 3 questions of the AUDIT) baseline; At 3 months post-training: change in audit-c score at baseline and 3 months post training
Other Time to first drink Time it takes between finalization of the training and the day the patients drinks an alcoholic beverage assessed at 3 months post-training
Other Time to first drink Time it takes between finalization of the training and the day the patients drinks an alcoholic beverage assessed at 6 months post-training
Other Time to first drink Time it takes between finalization of the training and the day the patients drinks an alcoholic beverage assessed at 1 year post-training
Other Time to first heavy drinking day Time it takes between finalization of the training and the day a female patient drinks = 4 alcoholic units/day and a male patient drinks = 5 alcoholic units/day assessed at 3 months post-training
Other Time to first heavy drinking day Time it takes between finalization of the training and the day a female patient drinks = 4 alcoholic units/day and a male patient drinks = 5 alcoholic units/day assessed at 6 monthspost-training
Other Time to first heavy drinking day Time it takes between finalization of the training and the day a female patient drinks = 4 alcoholic units/day and a male patient drinks = 5 alcoholic units/day assessed at 1 year post-training
Primary change in drink behavior AUDIT score baseline, at 6 months and 1-year post training: change in auditscores between baseline, 6 months and 1-year post-training, and differences between groups
Secondary change in Retraining attentional bias The effect on a VPT task baseline and between 1 and 7 days after completion of the 6 training sessions: change
Secondary change in Retraining action tendencies The effect on a AAT task baseline and between 1 and 7 days after completion of the 6 training sessions: change in action tendencies
See also
  Status Clinical Trial Phase
Completed NCT02901041 - Interdisciplinary Study of A Novel Anticonvulsant in Alcoholism Phase 3
Completed NCT03340051 - Remote Alcohol Monitoring and Episodic Thinking N/A
Completed NCT02705898 - Lifestyle Physical Activity Intervention for Depressed Alcohol Dependent Women N/A
Completed NCT02486900 - Neurofeedback & Alcohol Dependence N/A
Completed NCT02179749 - Mifepristone Treatment of Alcohol Use Disorder Phase 2
Completed NCT02197598 - Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use Phase 4
Recruiting NCT02385643 - The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients N/A
Completed NCT01828866 - Eye Movement Desensitization and Reprocessing (EMDR) in Alcohol Dependent Patients N/A
Terminated NCT01408641 - Topiramate for Alcohol Use in Posttraumatic Stress Disorder N/A
Active, not recruiting NCT01182766 - New Treatment for Alcohol and Nicotine Dependence Phase 2/Phase 3
Completed NCT02193204 - Chronic Alcohol, Stress Inflammatory Response and Relapse Risk N/A
Completed NCT01342549 - Treatment Strategy for Alcohol Use Disorders in Veterans With TBI Phase 3
Completed NCT01165541 - A Study of Quetiapine and Mirtazapine for the Treatment of Alcohol Dependency Phase 2
Completed NCT01176591 - HBPL Study of the Impact of the NK1 Antagonist Aprepitant Phase 2
Completed NCT01056484 - Mindfulness Meditation for Health Phase 2
Completed NCT00585780 - Prazosin to Reduce Stress-Induced Alcohol/Drug Craving and Relapse Phase 1/Phase 2
Completed NCT00607620 - Disseminating Organizational SBI Services at Trauma Centers N/A
Completed NCT00884884 - Aripiprazole and Topiramate on Free-Choice Alcohol Use Phase 2/Phase 3
Completed NCT00463346 - Treatment With Acamprosate in Patients With Schizophrenia and Comorbid Alcoholism Phase 3
Completed NCT00226694 - Alcohol and Gender Effects on Stress Circuit Function N/A